Business
US CONSIDERS ALLOWING MOST CHINESE PHARMACEUTICAL LICENSING DEALS
The US Treasury Department is developing rules that could allow American pharmaceutical companies to continue most licensing deals involving Chinese developed drugs. The proposed framework would reportedly focus restrictions on areas involving pathogens and biotechnology that could potentially be weaponized, while allowing most conventional drug licensing partnerships to continue.
BigV•2h ago•1 min read